首页 产品目录 分子砌块 按官能团 酰胺类 3-亚甲基-7-(吡唑并[1,5-a]吡啶-3-甲酰基)-2,7-二氮杂螺[4.4]壬烷-1-酮

3-亚甲基-7-(吡唑并[1,5-a]吡啶-3-甲酰基)-2,7-二氮杂螺[4.4]壬烷-1-酮

3-methylene-7-(pyrazolo[1,5-a]pyridine-3-carbonyl)-2,7-diazaspiro[4.4]nonan-1-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

943609-66-3

中文名称

3-亚甲基-7-(吡唑并[1,5-a]吡啶-3-甲酰基)-2,7-二氮杂螺[4.4]壬烷-1-酮

英文名称

3-methylene-7-(pyrazolo[1,5-a]pyridine-3-carbonyl)-2,7-diazaspiro[4.4]nonan-1-one

别名

Vedolizumab;Vedolizumab USP/EP/BP;Research Grade Vedolizumab(DHC98802);Vedolizumab (anti-α4β7-integrin);Research Grade Vedolizumab;Vedolizumab 62.6mg/ml

标准英文名

3-methylene-7-(pyrazolo[1,5-a]pyridine-3-carbonyl)-2,7-diazaspiro[4.4]nonan-1-one

分子式

C48H48N12O6

分子量

888.99

精确分子量

888.38

SMILES

C=C1CC2(CCN(C(=O)C3=C4C=CC=CN4N=C3)C2)C(=O)N1.C=C1CC2(CCN(C(=O)C3=C4C=CC=CN4N=C3)C2)C(=O)N1.C=C1CC2(CCN(C(=O)C3=C4C=CC=CN4N=C3)C2)C(=O)N1

标准SMILES

C=C1CC2(CN(CC2)C(=O)C2C=NN3C=CC=CC3=2)C(=O)N1.C=C1CC2(CN(CC2)C(=O)C2C=NN3C=CC=CC3=2)C(=O)N1.C=C1CC2(CN(CC2)C(=O)C2C=NN3C=CC=CC3=2)C(=O)N1

用途

Vedolizumab is a humanized monoclonal antibody targeting α4β7 integrin, approved by the U.S. FDA in May 2014 for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) who have had an inadequate response, loss of response, or intolerance to conventional therapy or a TNF-α antagonist; it is also used in research related to ulcerative colitis and Crohn's disease.

InChIKey

ZMLTXCHYIRTZLL-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  943609-66-3 逆合成路线 1

—
—
ACGMPN489
16205-46-2
ACJIQL769
943609-66-3
来源: SureRoute

2.  943609-66-3 逆合成路线 2

—
—
—
—
ACJIQL769
943609-66-3
来源: SureRoute

3.  943609-66-3 逆合成路线 3

—
—
ACJIQL769
943609-66-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手